Risk of second primary malignancies (SPM) following radioactive I-131 (RAI) therapy in patients with differentiated thyroid cancer (DTC)

被引：0
|
作者：
Ansari, Aiysha [1 ]
Kulkarni, Kanchan [1 ]
Van Nostrand, Douglas [1 ]
Khorjekarand, Gauri [1 ]
Garcia, Carlos [1 ]
机构：
[1] WHC, Nucl Med, Washington, DC USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1084
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC)
    Locati, L. D.
    Porcu, L.
    Seregni, E.
    Granata, R.
    Bossi, P.
    Bergamini, C.
    Mirabile, A.
    Torri, V.
    Bombardieri, E.
    Licitra, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 328 - 328
  • [2] TRANSIENT RADIATION EFFECTS FOLLOWING HIGH-DOSE I-131 THERAPY FOR DIFFERENTIATED THYROID-CANCER (DTC)
    KHAN, S
    WAXMAN, A
    RAMANNA, L
    ASHOK, G
    NAGARAJ, N
    BRAUNSTEIN, G
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P15 - P15
  • [3] Second primary tumors in thyroid cancer patients and its relationship to I-131 therapy
    Wang, W
    Larson, SM
    Sheikh, A
    Robbins, R
    RADIOLOGY, 2001, 221 : 343 - 343
  • [4] Second primary cancer after 131-iodine therapy in differentiated thyroid cancer (DTC) patients in the Veneto (Italy).
    Casara, D
    Saladini, G
    Rubello, D
    Mazzarotto, R
    Sotti, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 987 - 987
  • [5] THYROID CANCER FOLLOWING I-131 THERAPY OF HYPERTHYROIDISM
    LIMA, JB
    CATZ, B
    PERZIK, SL
    JOURNAL OF NUCLEAR MEDICINE, 1970, 11 (01) : 46 - &
  • [6] I-123 instead of serial I-131 tracers to predict the outcome of the I-131 post therapy scan in differentiated thyroid cancer, DTC prospectively the first 100 patients
    Britton, K
    Foley, RR
    Murray, IS
    El Megadmi, H
    Ali, N
    Sebastian, C
    Canizales, AL
    Plowman, PN
    Chew, SL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S431 - S431
  • [7] Radioactive Iodine (I-131) Therapy for Thyroglobulin Positive, Scan Negative Differentiated Thyroid Cancer.
    Alzahrani, Ali S.
    Alshaikh, Omalkhaire
    Al-Shehri, Sameerah
    Farhat, Rafif
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [8] Effects of Dosimetrically Guided I-131 Therapy on Hematopoiesis in Patients With Differentiated Thyroid Cancer
    Bikas, Athanasios
    Schneider, Mark
    Desale, Sameer
    Atkins, Frank
    Mete, Mihriye
    Burman, Kenneth D.
    Wartofsky, Leonard
    Van Nostrand, Douglas
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (04): : 1762 - 1769
  • [9] The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    THYROID, 2009, 19 (12) : 1381 - 1391
  • [10] THERAPEUTIC IMPLICATIONS OF DIFFUSE HEPATIC UPTAKE FOLLOWING I-131 THERAPY FOR DIFFERENTIATED THYROID CANCER
    Ferris, Heather A.
    Williams, Gethin
    Parker, J. Anthony
    Garber, Jeffrey R.
    ENDOCRINE PRACTICE, 2013, 19 (02) : 263 - 267
12345